PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsSulfur hexafluoride
Sulfur hexafluoride lipid microsphere
Sulfur hexafluoride lipid microsphere is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
lumasonNew Drug Application2025-07-22
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
Code
Description
Q9950
Injection, sulfur hexafluoride lipid microspheres, per ml
Clinical
Clinical Trials
205 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver neoplasmsD008113EFO_1001513C22.012411220
Hepatocellular carcinomaD006528C22.011111014
Retinal perforationsD012167EFO_100102811911
Wounds and injuriesD014947T14.811326
Abdominal injuriesD00000722316
Renal cell carcinomaD002292EFO_00003762114
HemorrhageD006470MP_0001914R58134
InfarctionD007238EFO_00094631124
Liver diseasesD008107EFO_0001421K70-K77134
Myocardial infarctionD009203EFO_0000612I211113
Show 7 more
Indications Phases 3
Indications Phases 2
Indications Phases 1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dissociative disordersD004213F44.188
Fuchs' endothelial dystrophyD005642EFO_0003946H18.5144
Pancreatic neoplasmsD010190EFO_0003860C2533
MicrocirculationD00883333
Vision disordersD014786H53.1122
Hereditary corneal dystrophiesD003317H18.522
CataractD002386EFO_0001059H26.922
Colonic neoplasmsD003110C1822
SepsisD018805EFO_0001420A41.922
Healthy volunteers/patients22
Show 95 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSulfur hexafluoride lipid microsphere
INN
Description
Sulfur hexafluoride lipid microsphere is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL3545306
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
Black-box warning for: Lumason
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,526 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use